Immuno-Cell Company Profile

16:43 EST 19th November 2017 | BioPortfolio

Manufacture of slides and cards for use in test kits.


Motstraat 72/8


Phone: 32 15 43 31 88
Fax: 32 15 43 11 21

News Articles [1512 Associated News Articles listed on BioPortfolio]

Catalent, Grid Therapeutics in Immuno-Oncology Alliance

Will leverage GPEx cell line technology to develop cell lines and manufacture antibodies for optimization

AbbVie and Harpoon Therapeutics Enter Immuno-Oncology Research Collaboration

NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Harpoon Therapeutics, a biotechnology company devel...

CRISPR Therapeutics, MGH Partner to Develop T-Cell Cancer Therapies

CRISPR Therapeutics and Massachusetts General Hospital Cancer Center (MGHCC) said today they will develop novel T cell therapies for blood and solid tumors by using CRISPR/Cas9 gene editing to improve...

Inovio Pharma begins phase 1b/2 immuno─oncology trial to evaluate atezolizumab in combo with INO─5401

Inovio Pharmaceuticals has announced initiation of a phase 1b/2 immuno─oncology trial to evaluate Genentech/Roche's atezolizumab (Tecentriq) in combination with Inovio's INO─5401, a T cell activat...

Amgen and CytomX Enter Immuno-Oncology Collaboration

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Oct. 3, 2017 /PRNewswire/ — Amgen (NASDAQ: AMGN) and CytomX Therapeutics, Inc., (NASDAQ: CTMX) today announced that the companies have ente...

Eutilex, Zhejiang Enter Immuno-Oncology Partnership

Aims to advance Eutilex's antibody and anti-tumor T cell therapy development programs

CellSight, Boehringer form Alliance for Anti-tumor T-Cell Activation Technology

The new technology could help to accelerate the development of critical immuno-oncological therapies

Is immuno-oncology shaping the oncology product development landscape?

Steven Powell, chief executive of UK-based immuno-oncology (I-O) company Macrophage Pharma, gives an…

Drugs and Medications [19 Associated Drugs and Medications listed on BioPortfolio]

Sun care [Zenith Medicosm SL]

Drug Facts

Sun care [Zenith Medicosm SL]

Drug Facts

Alimta [Eli Lilly and Company]

These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for ALIMTA. ALIMTA (pemetrexed for injection) Lyophilized Powder, for ...

Hycamtin [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use HYCAMTIN safely and effectively. See full prescribing information for HYCAMTIN. HYCAMTIN (topotecan) CapsulesInitial U.S. Approval: 19...

Patanol [Physicians Total Care, Inc.]

PubMed Articles [2777 Associated PubMed Articles listed on BioPortfolio]

Disseminated histoplasmosis in an immuno-competent young male: Role of bone marrow examination in rapid diagnosis.

Fungal infections are usually seen in elderly or immuno-compromised individuals particularly with human immunodeficiency virus infection. In immuno-competent individuals, they seldom present with over...

Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential.

Stem cell-based therapy is considered to be a new hope in transplantation medicine. Among stem cells, mesenchymal stem cells (MSCs) are, due to their differentiation and immuno-modulatory characterist...

A Case for a Human Immuno-Peptidome Project Consortium.

A multidisciplinary group of researchers gathered at the Hönggerberg Campus at ETH Zurich, Switzerland, for the first meeting on the Human Immuno-Peptidome Project (

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation.

New immuno-oncology (I-O) therapies that harness the immune system to fight cancer call for a re-examination of the traditional parametric techniques used to model survival from clinical trial data. M...

Immuno-MALDI (iMALDI) for quantifying AKT1 and AKT2 in breast and colorectal cancer cell lines and tumors.

The PI3K/AKT/mTOR pathway is one of the most commonly dysregulated signaling pathways that is linked to cancer development and progression, and its quantitative protein analysis holds the promise to f...

Clinical Trials [5954 Associated Clinical Trials listed on BioPortfolio]

Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma

Multi-center, prospective randomised phase III study evaluating capecitabine in combination with standard-immunotherapy versus standard-immunotherapy alone as first-line therapy in patient...

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

This study includes the additional use of radiation therapy in combination immunotherapy in order to determine whether the radiation may improve the response of non-small cell lung cancer ...

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

The purpose of this study is to evaluate the safety and effectiveness of CAR-T cell immunotherapy in treating with GD2 positive glioma patients.

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

The purpose of this research study is to test the effectiveness of three treatment arms that are designed to improve survival in patients with non-small cell lung cancer. Eligible subjects...

Companies [986 Associated Companies listed on BioPortfolio]

Immuno-Cell Int.

Immuno-Cell International © is specialized in the production of printed diagnostic slides and plates, for use in various types of diagnostic test kits. For the Diagnostic Industry (the manufactures o...


Manufacture of slides and cards for use in test kits.

NantCell, Inc.

NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by de...

Immuno Diagnostic Oy

Immuno Diagnostic Oy was established in 1983. Thus, we have a long experience in importing and marketing high quality reagents for diagnostics and research. We provide our customers with a wide range ...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "Immuno-Cell" on BioPortfolio

We have published hundreds of Immuno-Cell news stories on BioPortfolio along with dozens of Immuno-Cell Clinical Trials and PubMed Articles about Immuno-Cell for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno-Cell Companies in our database. You can also find out about relevant Immuno-Cell Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record